Table 1. Characteristics of patients... | American Society of Hematology

Table 1.

Characteristics of patients with acute megakaryocytic leukemia

Patient	ECOG study	Age (y)	Gender	WBC × 10⁹/L	Hb gm/dL	Plts × 10⁹/L	Peripheral blasts (%)	Marrow blasts (%)	Marrow fibrosis^*	Cycles of induction
1	E3489	43	F	6.1	8.2	86	53	64	3	1
2	E3489	53	M	2.3	14.0	33	7	10	3	1
3	E3489	54	M	1.5	8.2	820	2	32	1	1
4	E3489	37	M	35.2	8.7	1016	3	74	3	1
5	E3489	26	F	15.6	8.2	33	79	31	4	1
6	E3489	42	F	0.9	8.6	1000	4	61	3	2
7	E4995	52	F	1.0	8.6	57	0	59	NA	1
8	E1490	65	M	2.4	11.9	161	38	90	1	1
9	E1490	70	M	1.1	8.0	23	20	50	NA	1
10	E3483	59	M	1.5	9.3	34	16	NA	2	1
11	E3483	42	M	11.7	9.5	40	63	NA	3	2
12	E3483	48	M	1.0	9.4	1450	0	5	3	1
13	E3483	61	M	3.4	9.1	23	12	NA	2	2
14	E3483	39	F	3.8	6.7	330	14	15	3	2
15	E3483	18	F	8.5	10.2	319	1	50	4	2
16	PC486	35	M	1.7	10.5	73	0	99	3	1
17	PC486	38	M	1.0	9.9	12	2	90	NA	2
18	E3483	36	M	33.0	8.9	145	84	95	3	2
19	E3483	56	M	1.0	4.0	28	2	30	3	1
20	PC486	35	M	0.8	7.9	49	8	80	3	2

Patient	ECOG study	Age (y)	Gender	WBC × 10⁹/L	Hb gm/dL	Plts × 10⁹/L	Peripheral blasts (%)	Marrow blasts (%)	Marrow fibrosis^*	Cycles of induction
1	E3489	43	F	6.1	8.2	86	53	64	3	1
2	E3489	53	M	2.3	14.0	33	7	10	3	1
3	E3489	54	M	1.5	8.2	820	2	32	1	1
4	E3489	37	M	35.2	8.7	1016	3	74	3	1
5	E3489	26	F	15.6	8.2	33	79	31	4	1
6	E3489	42	F	0.9	8.6	1000	4	61	3	2
7	E4995	52	F	1.0	8.6	57	0	59	NA	1
8	E1490	65	M	2.4	11.9	161	38	90	1	1
9	E1490	70	M	1.1	8.0	23	20	50	NA	1
10	E3483	59	M	1.5	9.3	34	16	NA	2	1
11	E3483	42	M	11.7	9.5	40	63	NA	3	2
12	E3483	48	M	1.0	9.4	1450	0	5	3	1
13	E3483	61	M	3.4	9.1	23	12	NA	2	2
14	E3483	39	F	3.8	6.7	330	14	15	3	2
15	E3483	18	F	8.5	10.2	319	1	50	4	2
16	PC486	35	M	1.7	10.5	73	0	99	3	1
17	PC486	38	M	1.0	9.9	12	2	90	NA	2
18	E3483	36	M	33.0	8.9	145	84	95	3	2
19	E3483	56	M	1.0	4.0	28	2	30	3	1
20	PC486	35	M	0.8	7.9	49	8	80	3	2

ECOG = Eastern Cooperative Oncology Group; WBC = white blood cell.

As described by Bauermeister et al.31